Kidney Organoids Using Decellularized ECM for Vascularization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating kidney organoids face challenges in achieving sufficient vascularization and maturation, limiting their resemblance to adult kidney structures.
Innovation Solution
Culturing kidney organoids in a collagenous three-dimensional matrix incorporating decellularized kidney extracellular matrix (dECM) promotes vascularization and maturation by enhancing gene expression of key markers, and transplantation of these organoids into animal kidneys further supports vascular integration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If kidney organoids are cultured using conventional methods, then nephron-like structures can be formed, but vascularization and maturation remain insufficient
Solution Approach 1:
The patent uses decellularized extracellular matrix (dECM) as an intermediary material between the culture medium and kidney organoids. The dECM provides biochemical signals and structural support that promote vascularization and maturation without requiring direct complex manipulation of the organoids themselves
Solution Approach 2:
The patent changes the biochemical parameters of the culture environment by incorporating dECM-derived factors, growth factors, and matrix components. This alters the culture conditions to better mimic the in vivo kidney microenvironment, thereby improving organoid maturation
2Reliability
If kidney organoids are transplanted into animal kidneys or microfluidic systems, then vascularization improves, but the process remains complex and insufficient compared to adult kidneys
Solution Approach 1:
The patent extracts the essential vascularization-promoting components from complex transplantation systems by using decellularized matrix materials. This isolates the key beneficial factors (biochemical signals, structural framework) without the complexity of whole-organ transplantation or microfluidic device engineering
Solution Approach 2:
The patent applies dECM specifically to the kidney organoid culture environment, providing localized biochemical and structural cues where they are most needed. This targeted approach improves vascularization at the organoid level without requiring system-wide complexity
Data Source
AI summary
The present invention relates to a kidney organoid having a nephron-like structure and a production method therefor. A kidney organoid culture system using kidney dECM hydrogels according to the present invention induced the vascularization of the kidney organoid and the expression of podocytes, tubular transporters, and cilium genes, and has an effect of forming a more mature nephron-like structure. Therefore, the kidney organoid produced by the method of the present invention is an option for treating nephron loss through transplantation into humans, and is expected to be utilized as a kidney on a chip, which is an in vitro kidney model.